[Anti-arrhythmic activity of a new selenium-derivative preparation].
It has been demonstrated in an experimental calcium chloride model that piperidine-ethyl-selenophen belonging to the class of selenium derivatives is superior to isoptin in antiarrhythmic action. The drug shortens the duration of arrhythmia and reduces 2-3 times the time required for the recovery of heart rhythm, thereby raising the efficacy of therapy.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D008297:Male; D051379:Mice; D016566:Organoselenium Compounds; D010880:Piperidines / Q000627:therapeutic use*; D012643:Selenium / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D016566:Organoselenium Compounds; D010880:Piperidines; C041321:piperidine-ethyl-selenophene; D014700:Verapamil; D012643:Selenium
Protivoaritmicheskaia aktivnost' novogo selenoproizvodnogo preparata.